Related Experiment Video
Updated: Mar 3, 2026
06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
10.4K
Follow-up program in head and neck cancer.
Francesca De Felice1, Marco de Vincentiis2, Valentino Valentini3
1Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
Critical Reviews in Oncology/Hematology
|April 22, 2017
Summary
Standardizing head and neck cancer (HNC) follow-up care is crucial. This study proposes a structured surveillance program tailored to specific primary tumor sites for improved patient management.
Area of Science:
- Oncology
- Head and Neck Surgery
- Cancer Surveillance
Background:
- Effective follow-up programs are essential for head and neck cancer (HNC) patient management.
- Current clinical practice faces challenges due to a lack of consensus on optimal HNC surveillance protocols.
- Existing guidelines offer varied recommendations, complicating standardized patient care.
Purpose of the Study:
- To develop a standardized follow-up program for head and neck cancer (HNC) patients.
- To base the surveillance protocol on the specific primary tumor subsite.
- To improve the consistency of patient monitoring after HNC treatment.
Main Methods:
- Construction of a novel follow-up program.
- Stratification of the program based on primary HNC subsites.
- Standardization of patient surveillance protocols post-treatment.
Main Results:
- A structured follow-up program for head and neck cancer (HNC) was developed.
- The program standardizes surveillance based on primary tumor location.
- This approach aims to address the current clinical dilemma in HNC management.
Conclusions:
- A standardized, subsite-specific follow-up program can enhance head and neck cancer (HNC) patient surveillance.
- This structured approach offers a potential solution to the lack of consensus in HNC management.
- Implementation of this program may lead to more consistent and effective post-treatment care for HNC patients.
Related Concept Videos
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:19Veins of Head and Neck
6.4K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
6.4K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
01:21Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K